Lopez Carlos Luis — SEC Form 4 filings

SEC reporting owner CIK 2042509. 4 Form 4 filings on record with FilingPulse; latest filed 2026-07-08.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-02-14 to 2026-07-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Niagen Bioscience, Inc. (NAGE)SVP, General Counsel41 leg · 273 sh · $2,1463

Form 4 filings — Lopez Carlos Luis

FiledFormIssuerReported transactionsSource
2026-07-084Niagen Bioscience, Inc. (NAGE)Grant/award (A): 2,314 @ $2.71EDGAR
2026-02-244Niagen Bioscience, Inc. (NAGE)Grant/award (A): 41,420 (derivative) @ $0EDGAR
2025-03-104ChromaDex Corp. (CDXC)Purchase (P): 273 @ $7.86EDGAR
2025-02-144ChromaDex Corp. (CDXC)Grant/award (A): 19,691 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2042509 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →